{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-087838","form_type":"8-K","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.963167+00:00","generated_at":"2026-05-31T10:31:02.863363+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Zura Bio reports 97.2% of public warrants and 69% of private warrants tendered in exchange offer","bullets":["6,703,428 public warrants (~97.2%) and 4,080,580 private placement warrants (~69.0%) validly tendered; settlement expected by Aug 12, 2024.","Each tendered warrant exchanged for 0.30 Class A ordinary shares; remaining untendered warrants to be converted into 0.27 shares (10% less).","Consents received to amend warrant agreement; post-offer exchange will eliminate all outstanding IPO warrants.","Cantor Fitzgerald acted as dealer manager; Alliance Advisors as information agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-087838","json":"https://secwatch.observer/filing/0001104659-24-087838.json","markdown":"https://secwatch.observer/filing/0001104659-24-087838.md","text":"https://secwatch.observer/filing/0001104659-24-087838.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465924087838/0001104659-24-087838-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465924087838/tm2421034d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:31:02.863363+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}